Tayler Shaw

As part of an international program, Almira Manzano, MD, a retina specialist in the Philippines, spent three months learning at CU.

Novel research looks at the prevalence of a type of brain injury among people hospitalized with an opioid overdose.

Ophthalmologist Garrett “Conner” Nix, MD, explains the main eye-related issues skiers and snowboarders face.

Could a virtual reality headset offer a cheaper, easier, and more comfortable method of testing a person's vision, particularly among patients with a degenerative eye condition called geographic atrophy? It's a question that ophthalmologists like Jesse Smith, MD, an associate professor in the University of Colorado Anschutz Department of Ophthalmology, are exploring—and preliminary findings indicate positive potential.

Public interest in drugs known as glucagon-like peptide-1 receptor agonists, also called GLP-1 RAs, has surged in recent years, with popular types like semaglutide (sold under brand names like Ozempic and Wegovy) becoming known for their weight-loss effects.

For many years, older adult patients who fractured their hip typically spent most of their recovery time with orthopedic doctors, working to regain their strength and function. But for some of those patients, that care only addressed part of their health issue, explains Michael McDermott, MD, a national endocrinology expert in the University of Colorado Anschutz Department of Medicine.

CU Anschutz ophthalmologists and AI researchers are collaborating to incorporate artificial intelligence into eye health care to help infants.

A CU Anschutz ophthalmologist shares the potential pros and cons of an experimental procedure that implants a wireless chip in the eye of patients with AMD.

Samantha Farro, PhD, directs the integrated behavioral health program at the UCHealth Seniors Clinic, which helps patients get care faster.

A part-time, online fellowship at CU Anschutz helps mid-career physicians get board certified in hospice and palliative medicine.